Sunday, 16 December 2018

UK- India collaborate to curb AMR

14 September 2018 | News

The three-year DOSA programme will begin with a meeting of the project group on 24-25 September at the Indian Institute of Technology Delhi (IIT-D).

Image credit- chemistryworld.com

Image credit- chemistryworld.com

A £3 million interdisciplinary research project will address the growing threat of drug-resistant infections in India. The project will develop innovative diagnostics to curb antimicrobial resistance (AMR), one of the biggest threats to global public health.

The DOSA programme - Diagnostics for One Health and User Driven Solutions for AMR - brings together nine leading academic institutions, five from India and four from the UK.

The three-year DOSA programme will begin with a meeting of the project group on 24-25 September at the Indian Institute of Technology Delhi (IIT-D).

The project is jointly funded by UK Research and Innovation/Economic and Social Research Council, the Newton Fund, and Government of India's Department of Biotechnology.

Indian partners include the Indian Institute of Technology Delhi; the Centre for Cellular and Molecular Platforms Bengaluru; ICAR-Central Institute of Fisheries Technology, Cochin, Kerala; ICAR-National Dairy Research Institute, Karnal, Haryana; Silchar Medical College and Assam University, Silchar, Assam.

UK partners include the Universities of Edinburgh, Bradford and Southampton and University of the Arts London.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Does Indian Pharma lack an innovation-friendly ecosystem?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls